These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3539687)

  • 1. [Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias].
    Bracchetti D; Naccarella F; Guaragna RF; Palmieri M; Bartoletti A; Barbato G; Malini PL; Marchesini B; Ambrosioni E
    G Ital Cardiol; 1986 Aug; 16(8):648-59. PubMed ID: 3539687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of Holter's dynamic ECG a as predictor of the effectiveness of anti-arrhythmia therapy].
    Sanna GP
    G Ital Cardiol; 1986 Aug; 16(8):663-6. PubMed ID: 3792732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Control of the efficacy of anti-arrhythmic treatments].
    Coumel P
    Schweiz Med Wochenschr; 1981 Nov; 111(45):1688-91. PubMed ID: 7313633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of Holter electrocardiogram in the evaluation of anti-arrhythmia therapy].
    Meoli P; Sanna G
    G Ital Cardiol; 1987 Dec; 17(12):1114-20. PubMed ID: 3332646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of serum drug level monitoring during therapy with class III antiarrhythmic agents.
    Follath F
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S41-3. PubMed ID: 1279308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the noninvasive approach.
    Andresen D; Behrens S; Stern R; Brüggemann T; Schröder R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S28-31. PubMed ID: 1279306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methods of antiarrhythmic drug evaluation in man].
    Libersa C; Caron J; Guedon-Moreau L; Tricot O; Bordet R
    Therapie; 1994; 49(3):201-9. PubMed ID: 7878585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment with the new antiarrhythmic drug propafenone in correlation to plasma levels (author's transl)].
    Wiebringhaus E; Seipel L; Breithardt G; Loogen F
    Z Kardiol; 1977 Nov; 66(11):625-32. PubMed ID: 22958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of pharmacokinetics for antiarrhythmic drugs.
    Harrison DC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of plasma concentrations of anti-arrhythmia agents].
    Flouvat B
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ventricular arrhythmias: diagnosis and drug therapy].
    Schüpfer C; Gertsch M
    Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of ambulatory ECG in a cardiology department].
    Pesola A; Magini G
    G Ital Cardiol; 1987 Dec; 17(12):1055-62. PubMed ID: 3503801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.